Effect of dual SGLT1/ SGLT2 inhibitor sotagliflozin on renal outcomes in type 1 and type 2 diabetes mellitus : a systematic review and meta-analysis of randomised controlled trials
| dc.contributor.author | Bantounou, Maria A. | |
| dc.contributor.author | Sardellis, Panagiotis | |
| dc.contributor.author | Thuemmler, Rosa J. | |
| dc.contributor.author | Boada, Daniel Black | |
| dc.contributor.author | Kaczmarek, Justyna | |
| dc.contributor.author | Mahmood, Ribeya | |
| dc.contributor.author | Plascevic, Josip | |
| dc.contributor.author | Phillips, Sam | |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2024-01-15T16:15:01Z | |
| dc.date.available | 2024-01-15T16:15:01Z | |
| dc.date.issued | 2024-02 | |
| dc.description | Open Access via the Wiley agreement We acknowledge the contribution of Giulia Terzoli in the conceptualization of the study and of Melanie Bickerton in developing and verifying the search strategy used for this review. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 1837426 | |
| dc.identifier | 282297777 | |
| dc.identifier | 5d3f738a-f6d4-42f2-a426-237a3702b058 | |
| dc.identifier | 38031239 | |
| dc.identifier | 85178243030 | |
| dc.identifier.citation | Bantounou, M A, Sardellis, P, Thuemmler, R J, Boada, D B, Kaczmarek, J, Mahmood, R, Plascevic, J & Phillips, S 2024, 'Effect of dual SGLT1/ SGLT2 inhibitor sotagliflozin on renal outcomes in type 1 and type 2 diabetes mellitus : a systematic review and meta-analysis of randomised controlled trials', Diabetes, Obesity & Metabolism, vol. 26, no. 2, pp. 710-720. https://doi.org/10.1111/dom.15364 | en |
| dc.identifier.doi | 10.1111/dom.15364 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 1462-8902 | |
| dc.identifier.uri | https://hdl.handle.net/2164/22554 | |
| dc.identifier.vol | 26 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Diabetes, Obesity & Metabolism | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Effect of dual SGLT1/ SGLT2 inhibitor sotagliflozin on renal outcomes in type 1 and type 2 diabetes mellitus : a systematic review and meta-analysis of randomised controlled trials | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Bantounou_etal_DOM_Effect_of_the_Dual_VOR.pdf
- Size:
- 1.75 MB
- Format:
- Adobe Portable Document Format
